Alpha-1 antagonist treatment for eyelid retraction in patients with thyroid eye disease-a prospective pilot study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Roee,Arnon

第一单位： The Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel, Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.;Ophthalmology Department, Assuta Ashdod Hospital, Ashdod, Israel.

作者： Roee,Arnon ^[1] ; Hila,Goldberg ^[2] ; Guy J,Ben-Simon ^[2] ; Ayelet,Priel ^[2] ; Ofira,Zloto ^[2] ; Daphna,Landau-Prat ^[2] ; Tali,Cukierman-Yaffe ^[3] ; Nancy,Agmon-Levin ^[4] ; Oded,Sagiv ^[5]

作者单位： The Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel, Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.;Ophthalmology Department, Assuta Ashdod Hospital, Ashdod, Israel. ^[1] The Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel, Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ^[2] The Endocrinology Institute, Sheba Medical Center, Tel Hashomer, Israel, Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ^[3] The Clinical Immunology, Angioedema and Allergy Unit, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel, Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ^[4] The Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel, Affiliated to the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. osagiv@mdanderson.org.;Section of Ophthalmology, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. osagiv@mdanderson.org. ^[5]